期刊文献+

血清sB7-H4检测在胃癌诊断中的价值 被引量:1

下载PDF
导出
摘要 目的探讨血清可溶性B7-H4(sB7-H4)检测对胃癌的诊断价值。方法采用酶联免疫吸附测定(ELISA)法检测50例胃癌患者、30例慢性胃炎患者和30例健康志愿者血清sB7-H4水平,并分析胃癌患者血清sB7-H4水平与临床病理参数的关系。结果胃癌组血清sB7-H4浓度为(48.26±12.32)ng/mL,显著高于胃炎组[(33.53±10.29)ng/mL]和对照组[(28.40±9.24)ng/mL],差异均有统计学意义(P<0.05)。胃癌组患者血清sB7-H4浓度与肿瘤TNM分期、分化程度及有无淋巴结转移相关(P<0.05),但与年龄、性别、肿瘤大小及病理组织类型无关。结论 sB7-H4与胃癌发生、发展及转移相关,可作为胃癌诊疗的潜在血清标志物。
出处 《国际检验医学杂志》 CAS 2013年第21期2920-2922,共3页 International Journal of Laboratory Medicine
  • 相关文献

参考文献19

  • 1PodojilJR, Miller SD. Targeting the B7 family of co-stimulatory molecules: successes and challenges DJ. BioDrugs, 2013, 27( 1) : 1- 13.
  • 2Yu N, Li X, Zheng S, et al. B7-H4' s Role" Beyond the Tumor"[J]. Inflammation, 2013 Apr 21.[Epub ahead of printJ.
  • 3Ochoa A,Chen L,Zou W. B7-H4 expression identifies a novel sup?pressive macrophage population in human ovarian carcinom[J].J Exp Med,2006,203(4) :871-881.
  • 4王小梅,胡国艳,刘伟,郑淑华,吕晶,王红梅,徐军发.血液系统恶性肿瘤患者血清可溶性B7-H4的检测及其临床意义[J].细胞与分子免疫学杂志,2010,26(9):893-894. 被引量:6
  • 5姜孝新,伍小平,蒋艳.肺癌患者血清可溶性B7-H4分子的检测及其临床意义[J].武汉大学学报(医学版),2012,33(1):81-83. 被引量:7
  • 6胡国艳,郑淑华,刘伟,那志萍,肖欢,张良清,徐军发.检测可溶性B7-H4 ELISA夹心法的建立[J].细胞与分子免疫学杂志,2008,24(8):831-833. 被引量:29
  • 7Sica GL,Choi IH,Zhu G,et al. B7-H4,a molecule of the B7 fami?ly, negatively regulates T cell immunity[J]. Immunity. 2003,18 (6) : 849-86l.
  • 8He C, Qiao H ,Jiang H, et al. The inhibitory role of b7-h4 in anti?tumor immunity: association with cancer progression and survival[n. Clin Dev Immunol.2011.2011 :695834.
  • 9FauciJM. StraughnJMJr. Ferrone S, et al. A review of B7-H3 and B7-H4 immune molecules and their role in ovarian cancer[J]. Gynecol Oncol , 2012,127(2) : 420-425.
  • 10Zhang L.Wu H.Lu D.et al. The costimulatory molecule B7-H4 promote tumor progression and cell proliferation through translo?eating into nucleus[J]. Oncogene. 2013Jan 14.[Epub ahead of print].

二级参考文献55

  • 1华建江,姜健,胡国艳,郑淑华,刘伟,吕晶,徐军发.胃癌患者血清可溶性B7-H4的检测及其临床意义[J].山东大学学报(医学版),2009,47(8):100-102. 被引量:1
  • 2毛一香,张学光.B7-H4——B7家族的又一新成员[J].中国免疫学杂志,2005,21(5):395-397. 被引量:6
  • 3李锦洲,盛家和,陈光意.肿瘤标记物检测在消化系统肿瘤诊断中作用[J].医药论坛杂志,2005,26(14):25-26. 被引量:5
  • 4Yi-xiang MAO,Yong-Jing CHEN,Yan GE,Hong-bing MA,Jian-feng YU,Hong-ya WU,Yu-min HU,Qin WANG,Qin SHI,Xue-guang ZHANG.Recombinant human B7-H4 expressed in Escherichia coli inhibits T lym-phocyte proliferation and IL-2 secretion in vitro[J].Acta Pharmacologica Sinica,2006,27(6):741-746. 被引量:16
  • 5FLIES D B,CHEN L.The new B7s:playing a pivotal role in tumor immunity[J].J Immunother,2007,30(3):251-260.
  • 6BOENISCH O,SAYEGH M H,NAJAFIAN N.Negative T-cell costimulatory pathways:their role in regulating alloimmune responses[J].Curr Opin Organ Transplant,2008,13(4):373-378.
  • 7AWADALLAH N S,SHROYER K R,LANGER D A,et al.Detection of B7-H4 and p53 in pancreatic cancer:potential role as a cytological diagnostic adjuct[J].Pancreas,2008,36(2):200-206.
  • 8SIMON I,ZHUO S Q,CORRAL L,et al.B7-H4 Is a Novel membrane-bound protein and a candidate serum and tissue biomarker for ovarian cancer[J].Cancer Research,2006,66(3):1 570-1 575.
  • 9ZHANG G B,HOU J Q,SHI J F,et al.Soluble CD276 (B7-H3) is released from monocytes,dendritic cells and activated T cells and is detectable in normal human serum[J].Immunology,2008,123(4):538-546.
  • 10CHOI I H,ZHU G,SICA G L,et al.Genomic organization and expression analysis of B7-H4,an immune inhibitory molecule of the B7 family[J].J Immunol,2003,171(9):4 650-4 654.

共引文献54

同被引文献13

  • 1Sica GI,, Choi IH, Zhu G, et al. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity [ J ]. hnmunity, 2003,18(6) :849 -861.
  • 2Prasad DV, Richards S, Mai XM, et tl. B7S1, a novel B7 family meml)er that negatively regulates T cell activation [ J ]. hnmunity,2003,18(6) :863 -873.
  • 3Zang X, Loke P, Kim J,et al. B7x: a widely expressed B7 family member that inhibits T cell activation [ J ]. Proe Natl Aead Sei USA ,2003,100( 18 ) : 10388 - 10392.
  • 4Saleeda S,Tang T, Kmet M,et al. The imnmnomodulatory protein B7-1t4 is overexpressed in breast and ovarian eaneers and promotes epithelial cell transformation [ J ]. Experimental Cell Research ,2005,306 ( 1 ) : 128 - 141.
  • 5Simon l,Katsams D,Rigauh de la l.ongrais l,et a/. B7-H4 is over- expressed in em'ly-stage ovarian cancer and is independent of CAI25 expressian [ J ]. Gynecol Onco1,2007,106 ( 1 ) :334 - 341.
  • 6Sun Y,Wang Y ,Zhao J,et al. BT-H3 and B7-tt4 expression in non- snl-eell lung cancer [ J ]. Lung Cancer,2006,53 ( 2 ) : 143 - 151.
  • 7Arlgami T, Uenosono Y, tlirata M,et al. Expression of B7-tt4 in blood of patients with gastric cancer predicts tumor progression and prognosis [ J]. J Surg Onco1,2010,102(7) :748 -752.
  • 8Crispen PI,, Boorjian SA, l,ohse CM, et al. Predicting disease progression 'after nephrectomy tbr localized renal cell careinanm: the utility of prognostie models and molecular biomarkers [ J ]. Cancer,2008,113 ( 3 ) :450 - 460.
  • 9Choi IH, Zhu G, Siea GL, et al. Genomic organization and expression analysis of B7-H4 an immune inhilfitory moteeuh, of the B7 family [ J ]. hnmunol,2003,171 ( 9 ) :4650 - 4654.
  • 10Krambeck AE,Thompson RH, Dong H,et al. B7-H4 expression in renal cell carcinoma and tumor vasculature ass(:iations with cancer progression and survival [. J ]. Proc Natl Aead Sci USA. 2006,103 ( 27 ) : 10391 - 10396.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部